Stock screener

JNJ

Conviction 69HealthcareScan · Mon, Jul 20, 2026
JNJ$248.85-1.66%
ResistanceSupportVol 14Congress buyCongress sell
63 bars
Thomas H. Kean
Thomas H. Kean
Lloyd Doggett
Vol MA14 8.1M
Apr 20May 6May 26Jun 11Jul 1Jul 20
WSB mentions · 24h changelatest +0.00%· 1 mentions
Apr 20May 6May 26Jun 11Jul 1Jul 20
JOHNSON & JOHNSONPHARMACEUTICAL PREPARATIONSwww.jnj.com
Price248.85
Change-1.66%
Gap-0.50%
Rel volume0.95×
Avg volume8.84M
Avg $ vol2.23B
SMA 20252.85
SMA 50239.14
SMA 200223.24
Price vs 50+4.06%
Price vs 200+11.47%
MA stackbullish
50/200 cross
Supertrenddown · 269.03
RSI (14)50
MACD hist-1.74
MACD crossbear · 4d
Stoch %K / %D12 / 20
ADX (14)26
+DI / −DI25 / 24
RSI divergence
MACD divergence
ATR %+2.48%
ADR %2.30%
52w high267.24
52w low163.70
From 52w high-6.88%
Above 52w low+52.02%
New 52w highNo
SqueezeOff
Bollinger width13.70%
%B0.38
Donchian pos50.92%
Donchian high269.43
Donchian low227.50
AVWAP (52w high)255.87
vs AVWAP high-2.74%
AVWAP (52w low)213.18
vs AVWAP low+16.73%
OBV trendUp
Chaikin MF (20)0.08
Today vs 20d0.95×
Avg vol (14d)8.1M
Avg vol (20d)8.84M
Avg $ vol (20d)2.23B
Market cap599.04B
RS 3m (vs SPY)+1.95%
RS 6m (vs SPY)+8.11%
RS line new highNo
Trend template8/8
Technical rank78.6
1 week-3.46%
1 month+6.26%
3 months+6.26%
6 months+13.34%
1 year+52.69%
YTD+20.01%
P/E22.35
P/B7.38
P/S6.36
P/FCF30.41
EPS11.03
Div yield
ROE33.02%
ROA13.34%
Debt/Eq0.49
Current1.03
EV/EBITDA21.20
Gross margin67.88%
Net margin28.46%
Rev growth6.05%
EPS growth90.56%
Price target279.19
Target upside12.19%
Analyst ratingBuy
Institutional85.43%
Ent. value616.87B
Revenue24.06B
Net income5.24B
Gross profit15.96B
Free cash flow19.7B
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNYSE
Shares out2.41B
Employees140.8K
ListedMon, Sep 25, 1944
Free float2.41B
Float %100.0%
Short interest26.58M
Days to cover2.5d
Short volume55.1%
Squeeze score25 / 100
Next earnings
EPS forecast
Last EPS vs est$2.90 vs $2.84
Last surprise+2.1% beat
Setup gradeB
Conviction69 / 100
Pattern quality
Tech rank78.6 / 100
Group rank23 / 100
Status lane
Setup direction
Pattern family
Resistance255.52
Support224.17
Days since event
Candle confirm
News sentiment

Financials as of Sun, Mar 29, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in JNJ · 10 recent

All disclosures →
MemberSideAmount
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2026-06-29
Sell$1K–$15K
Thomas H. Kean
Thomas H. Kean
house · R · NJ · traded 2026-06-02
Sell$1K–$15K
Lloyd Doggett
Lloyd Doggett
house · D · TX · traded 2026-06-09
Buy$1K–$15K
John Boozman
John Boozman
senate · R · AR · traded 2026-03-19
Sell$1K–$15K
Lloyd Doggett
Lloyd Doggett
house · TX · traded 2025-12-09
Buy$1K–$15K
Jared Moskowitz
Jared Moskowitz
house · D · FL · traded 2025-10-10
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-30
Sell$1K–$15K
Lisa McClain
Lisa McClain
house · MI · traded 2025-10-31
Sell$1K–$15K
Valerie Hoyle
Valerie Hoyle
house · D · OR · traded 2025-09-23
Sell$1K–$15K
Sheri Biggs
Sheri Biggs
house · R · SC · traded 2025-03-19
Sell$15K–$50K

Insider activity

SEC Form 4 transactions in JNJ · 8 buys · 2 sells

InsiderSideShares
REED JOHN C
EVP, Innovative Medicine, R&D · Common Stock · 2026-05-01
Exercise25.25K
REED JOHN C
EVP, Innovative Medicine, R&D · Common Stock · 2026-05-01
Tax11K
REED JOHN C
EVP, Innovative Medicine, R&D · Restricted Share Units · 2026-05-01
Exercise25.25K
West Nadja
Director · Deferred Share Units · 2026-04-23
Grant975
Pinto Daniel E
Director · Deferred Share Units · 2026-04-23
Grant1.71K
MORIKIS JOHN G
Director · Deferred Share Units · 2026-04-23
Grant1.54K
Beckerle Mary C
Director · Deferred Share Units · 2026-04-23
Grant975
HEWSON MARILLYN A
Director · Deferred Share Units · 2026-04-23
Grant975
Joly Hubert
Director · Deferred Share Units · 2026-04-23
Grant975
Woods Eugene A.
Director · Deferred Share Units · 2026-04-23
Grant975

SEC filings

EDGAR filings in JNJ · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.